Tobrex and Photophobia - a phase IV clinical study of FDA data

Summary:

Photophobia is reported as a side effect among people who take Tobrex (tobramycin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Tobradex, and have Eye oedema.

The phase IV clinical study analyzes which people have Photophobia when taking Tobrex. It is created by eHealthMe based on reports of 752 people who have side effects when taking Tobrex from the FDA, and is updated regularly.

What is Tobrex?

Tobrex has active ingredients of tobramycin. eHealthMe is studying from 762 Tobrex users. Check the latest studies of Tobrex.

What is Photophobia?

Photophobia (extreme sensitivity to light) is found to be associated with 1,287 drugs and 1,832 conditions by eHealthMe. Check the latest studies of Photophobia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

752 people reported to have side effects when taking Tobrex.
Among them, 17 people (2.26%) have Photophobia.

Among these 17 people:

How long have people been on Tobrex when they have Photophobia? *

What is the gender of people who have Photophobia when taking Tobrex? *

female: 73.33 %
male: 26.67 %

What is the age of people who have Photophobia when taking Tobrex? *

What are other drugs people take besides Tobrex? *

What are other side effects people have besides Photophobia? *

Keratitis (eye's cornea, the front part of the eye, becomes inflamed): 12 people, 70.59%
Eye Irritation: 12 people, 70.59%
Eye Pain: 12 people, 70.59%
Foreign Body Sensation In Eyes (feeling of something in eye): 12 people, 70.59%
Eye Inflammation: 11 people, 64.71%
Sinusitis (inflammation of sinus): 11 people, 64.71%
Eye Oedema (swelling or thickening of the macula, the area of the retina responsible for central vision): 11 people, 64.71%
Ocular Hypertension (intraocular pressure higher than normal): 11 people, 64.71%
Vision Blurred: 3 people, 17.65%
Visual Acuity Reduced (reduced clearness of vision): 2 people, 11.76%

What are the existing conditions these people have? *

Eye Oedema (swelling or thickening of the macula, the area of the retina responsible for central vision): 11 people, 64.71%
Eye Pain: 10 people, 58.82%
Ocular Hypertension (intraocular pressure higher than normal): 9 people, 52.94%
Eye Inflammation: 8 people, 47.06%
Blepharitis (chronic inflammation of the eyelid): 2 people, 11.76%
High Blood Pressure: 1 person, 5.88%
Corneal Abscess (a collection of pus in cornea): 1 person, 5.88%
Conjunctivitis (pink eye): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Tobrex and have Photophobia?

- Check whether Photophobia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tobrex:

Tobrex (762 reports)

Photophobia treatments and more:

Photophobia (21,346 reports)

Browse all side effects of Tobrex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Photophobia:

Photophobia (1,287 drugs)

Browse all the conditions that are associated with Photophobia:

Photophobia (1,832 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tobramycin (the active ingredients of Tobrex) and Tobrex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.